πŸ‡ΊπŸ‡Έ FDA
Patent

US 12030863

Prodrugs of urolithins and uses thereof

granted A61KA61K31/366A61K31/4025

Quick answer

US patent 12030863 (Prodrugs of urolithins and uses thereof) held by Amazentis SA expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/366, A61K31/4025, A61K45/06, A61P